Interrogation of nucleotide excision repair capacity: impact on platinum-based cancer therapy.
about
Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathyChemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancerRecognition of DNA Termini by the C-Terminal Region of the Ku80 and the DNA-Dependent Protein Kinase Catalytic SubunitSodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responsesAssociation between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patientsGender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy.Current advances in DNA repair: regulation of enzymes and pathways involved in maintaining genomic stability.DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer.Regulation of XPC deubiquitination by USP11 in repair of UV-induced DNA damage.Nucleotide Excision Repair: From Neurodegeneration to Cancer.Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.
P2860
Q33798999-3EA474CC-BD70-4C60-9913-42AF6E3468ADQ33940195-E9F844DB-66EC-4417-BE08-ABFDAC494742Q34133825-638033C3-A262-4CF9-B821-421BB4D5A595Q34849073-9CE56D07-3982-45ED-B671-80BD61C9D917Q35610777-5F457960-7866-4FF6-9448-551AD20CA1FEQ35892810-65BE656B-7E07-49B4-A154-DABD155D2C97Q36629248-9CA7ED69-2E75-4B63-B7EE-61BC744F4B6EQ37332789-48EB608A-1BD6-461D-8F86-6D50E59CD621Q39028215-F0E07DB7-ECD9-4CE7-988A-96D81E82CC90Q42735393-BB4F78B8-3E40-4DA3-9783-2EA8E8AFB6FFQ44386340-A38ECE4D-F8B6-4DB4-8D37-D64AE0672696Q47143137-49D2D73C-D76B-408C-9126-F54C4CB5E474Q50428930-95B9B734-0BAF-473D-9902-96CDD03AA269Q50900131-4202E2CF-16B5-4813-9C05-22E8D3C9BE1C
P2860
Interrogation of nucleotide excision repair capacity: impact on platinum-based cancer therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Interrogation of nucleotide ex ...... platinum-based cancer therapy.
@en
Interrogation of nucleotide ex ...... platinum-based cancer therapy.
@nl
type
label
Interrogation of nucleotide ex ...... platinum-based cancer therapy.
@en
Interrogation of nucleotide ex ...... platinum-based cancer therapy.
@nl
prefLabel
Interrogation of nucleotide ex ...... platinum-based cancer therapy.
@en
Interrogation of nucleotide ex ...... platinum-based cancer therapy.
@nl
P2860
P356
P1476
Interrogation of nucleotide ex ...... platinum-based cancer therapy.
@en
P2093
Jennifer N Earley
John J Turchi
P2860
P304
P356
10.1089/ARS.2010.3369
P577
2011-01-23T00:00:00Z